MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.04MP/E –Yield –
MiMedx cash
Cash and short-term investments held at the end of each period.
MiMedx's cash was $120.79M at Sep 30, 2026. For fiscal 2025 it was $166.12M, up 59.1% from the year before. Over ten years it grew 18.9% a year on average. The highest annual figure on record is $166.12M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $166.12M | +59.1% |
| FY2024 | Dec 31, 2024 | $104.42M | +27.3% |
| FY2023 | Dec 31, 2023 | $82.00M | +24.3% |
| FY2022 | Dec 31, 2022 | $65.95M | -24.3% |
| FY2021 | Dec 31, 2021 | $87.08M | -9.1% |
| FY2020 | Dec 31, 2020 | $95.81M | +38.7% |
| FY2019 | Dec 31, 2019 | $69.07M | +53.1% |
| FY2018 | Dec 31, 2018 | $45.12M | +64.2% |
| FY2017 | Dec 31, 2017 | $27.48M | -9.4% |
| FY2016 | Dec 31, 2016 | $30.32M | +3.5% |
| FY2015 | Dec 31, 2015 | $29.30M | -44.0% |
| FY2014 | Dec 31, 2014 | $52.33M | +18.7% |
| FY2013 | Dec 31, 2013 | $44.08M | +552.6% |
| FY2012 | Dec 31, 2012 | $6.75M | +64.2% |
| FY2011 | Dec 31, 2011 | $4.11M | +206.7% |
| FY2010 | Dec 31, 2010 | $1.34M | -49.5% |
| FY2009 | Dec 31, 2009 | $2.65M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $120.79M | -15.0% |
| Q2 FY2026 | Jun 30, 2026 | $135.84M | +14.3% |
| Q1 FY2026 | Mar 31, 2026 | $159.77M | +50.1% |
| Q4 FY2025 | Dec 31, 2025 | $166.12M | +59.1% |
| Q3 FY2025 | Sep 30, 2025 | $142.08M | +60.0% |
| Q2 FY2025 | Jun 30, 2025 | $118.87M | +72.2% |
| Q1 FY2025 | Mar 31, 2025 | $106.43M | +119.5% |
| Q4 FY2024 | Dec 31, 2024 | $104.42M | +27.3% |
| Q3 FY2024 | Sep 30, 2024 | $88.80M | +9.4% |
| Q2 FY2024 | Jun 30, 2024 | $69.04M | +0.6% |
| Q1 FY2024 | Mar 31, 2024 | $48.49M | -20.8% |
| Q4 FY2023 | Dec 31, 2023 | $82.00M | +24.3% |
| Q3 FY2023 | Sep 30, 2023 | $81.16M | +10.9% |
| Q2 FY2023 | Jun 30, 2023 | $68.65M | -5.3% |
| Q1 FY2023 | Mar 31, 2023 | $61.22M | -19.1% |
| Q4 FY2022 | Dec 31, 2022 | $65.95M | -24.3% |
| Q3 FY2022 | Sep 30, 2022 | $73.22M | -19.2% |
| Q2 FY2022 | Jun 30, 2022 | $72.50M | -14.7% |
| Q1 FY2022 | Mar 31, 2022 | $75.68M | -10.7% |
| Q4 FY2021 | Dec 31, 2021 | $87.08M | -9.1% |
| Q3 FY2021 | Sep 30, 2021 | $90.61M | -17.3% |
| Q2 FY2021 | Jun 30, 2021 | $85.01M | +76.4% |
| Q1 FY2021 | Mar 31, 2021 | $84.75M | +58.3% |
| Q4 FY2020 | Dec 31, 2020 | $95.81M | +38.7% |
| Q3 FY2020 | Sep 30, 2020 | $109.60M | +16.4% |
| Q2 FY2020 | Jun 30, 2020 | $48.19M | -50.3% |
| Q1 FY2020 | Mar 31, 2020 | $53.53M | +88.6% |
| Q4 FY2019 | Dec 31, 2019 | $69.07M | +53.1% |
| Q3 FY2019 | Sep 30, 2019 | $94.12M | +108.9% |
| Q2 FY2019 | Jun 30, 2019 | $96.93M | +118.6% |
| Q1 FY2019 | Mar 31, 2019 | $28.38M | +7.3% |
| Q4 FY2018 | Dec 31, 2018 | $45.12M | +64.2% |
| Q3 FY2018 | Sep 30, 2018 | $45.06M | +23.4% |
| Q2 FY2018 | Jun 30, 2018 | $44.34M | -6.7% |
| Q1 FY2018 | Mar 31, 2018 | $26.45M | -14.5% |
| Q4 FY2017 | Dec 31, 2017 | $27.48M | -9.4% |
| Q3 FY2017 | Sep 30, 2017 | $36.52M | – |
| Q2 FY2017 | Jun 30, 2017 | $47.53M | – |
| Q1 FY2017 | Mar 31, 2017 | $30.92M | – |
| Q4 FY2016 | Dec 31, 2016 | $30.32M | – |
See a number that looks wrong?